tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
Advertisement

Spyre Therapeutics (SYRE) Technical Analysis

Compare
476 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Spyre Therapeutics’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is 1.33, suggesting Spyre Therapeutics is a Buy.
Spyre Therapeutics’s (SYRE) 20-Day exponential moving average is 22.28, while Spyre Therapeutics’s (SYRE) share price is $22.39, making it a Buy.
Spyre Therapeutics’s (SYRE) 50-Day exponential moving average is 20.02, while Spyre Therapeutics’s (SYRE) share price is $22.39, making it a Buy.

Spyre Therapeutics (SYRE) Pivot Points

Nov 08, 2025, 07:02 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.62
21.32
22.09
22.79
23.56
24.26
25.03
Fibonacci
21.32
21.88
22.23
22.79
23.35
23.70
24.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Nov 08, 2025, 07:02 AM
Period
Simple
Exponential
MA5
23.29Sell
23.06Sell
MA10
23.71Sell
23.14Sell
MA20
22.72Sell
22.28Buy
MA50
18.89Buy
20.02Buy
MA100
17.55Buy
18.73Buy
MA200
17.45Buy
19.25Buy
Spyre Therapeutics’s (SYRE) 10-Day exponential moving average is 23.14, while Spyre Therapeutics’s (SYRE) share price is $22.39, making it a Sell.
Spyre Therapeutics’s (SYRE) 100-Day exponential moving average is 18.73, while Spyre Therapeutics’s (SYRE) share price is $22.39, making it a Buy.
Spyre Therapeutics’s (SYRE) stock price is $22.39 and Spyre Therapeutics’s (SYRE) 50-day simple moving average is 18.89, creating a Buy signal.
Spyre Therapeutics’s (SYRE) stock price is $22.39 and Spyre Therapeutics’s (SYRE) 100-day simple moving average is 17.55, creating a Buy signal.
Spyre Therapeutics’s (SYRE) stock price is $22.39 and Spyre Therapeutics’s (SYRE) 200-day simple moving average is 17.45, creating a Buy signal.

Spyre Therapeutics (SYRE) Technical Indicators

Nov 08, 2025, 07:02 AM
Name
Value
Implied Action
RSI (14)
54.68
Neutral
STOCH (9,6)
25.80
Neutral
STOCHRSI (14)
27.49
Neutral
MACD (12,26)
1.33
Buy
ADX (14)
36.19
Neutral
Williams %R
-83.94
Buy
CCI (14)
-16.98
Neutral
ATR (14)
1.29
-
Ultimate Oscillator
51.96
Neutral
ROC
-0.36
Sell
Spyre Therapeutics’s (SYRE) Relative Strength Index (RSI) is 54.68, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Trend Strength Indicator (ADX) is 36.19, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Commodity Channel Index (CCI) is -16.98, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Price Rate of Change (ROC) is -0.36, creating a Sell signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Hold.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 54.68, which suggests SYRE is a Neutral.
      What is SYRE’s MACD?
      SYRE’s MACD is 1.33, which suggests SYRE is a Buy.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 23.29, which suggests SYRE is a Sell.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 22.72, which suggests SYRE is a Sell.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 18.89, which suggests SYRE is a Buy.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 17.45, which suggests SYRE is a Buy.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -83.94, which suggests SYRE is a Buy.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is -16.98, which suggests SYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis